Form 4 for WST West Pharmaceutical Services
Accepted 2026-04-29 12:19:44 ET · period of report 2026-04-27 · accession 0000105770-26-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-29 12:19 | 2026-04-27 | WST | Winters Chad | VP, CAO | M - OptEx | $173.22 | +896 | 2,419 | +59% | +$155.2K |
| D | 2026-04-29 12:19 | 2026-04-27 | WST | Winters Chad | VP, CAO | S - Sale+OE | $300.67 | -896 | 1,523 | -37% | -$269.4K |
| D | 2026-04-29 12:19 | 2026-04-27 | WST | Winters Chad | VP, CAO | M - OptEx | $0.00 | -896 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-27 | M | A | 896 | $173.22 | 2,418.81 | D | — | — | |
| 2 | Common | Common Stock | 2026-04-27 | S | D | 896 | $300.67 | 1,522.81 | D | — | — | (F1) The price reported in column 4 is a weighted average price. |
| 3 | Derivative | Stock Options (Right to Buy) | 2026-04-27 | M | D | 896 | $0.00 | 0 | D | $173.22 · 2021-02-18 to 2030-02-18 | 896 Common Stock | (F2) This award granted on February 18, 2020 vested in four equal annual installments beginning on February 18, 2021. |